Stockreport

Publication by VBL Therapeutics Highlights MOSPD2 as a Potential New Target for Breast Cancer Therapy

Vascular Biogenics Ltd. - Ordinary Shares  (VBLT) 
Last vascular biogenics ltd. - ordinary shares earnings: 11/14 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: vblrx.com
PDF Paper on Role of MOSPD2 in Metastatic Breast Cancer Published in International Journal of Cancer TEL AVIV, Israel, July 10, 2018 (GLOBE NEWSWIRE) --  VBL Therapeutics [Read more]